Verastem Stock (NASDAQ: VSTM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 146.289K |
Day Range | - - - |
52 Wk Range | 4.260 - 15.180 |
Market Cap | $290.279M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 2.52% |
Days to Cover | 3.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verastem (NASDAQ: VSTM) through any online brokerage.
Other companies in Verastem’s space includes: Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for Verastem (NASDAQ: VSTM) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 17.50 expecting VSTM to rise to within 12 months (a possible 52.57% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Verastem (NASDAQ: VSTM) is $11.47 last updated April 17, 2024 at 9:04 AM EDT.
There are no upcoming dividends for Verastem.
Verastem’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Verastem.
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.